Medicare Enrolled
Dr. Henry Kriegstein, M.D.
Ophthalmology · Plymouth, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kriegstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kriegstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kriegstein
Dr. Henry Kriegstein is an ophthalmology specialist in Plymouth, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kriegstein performed 10,341 Medicare services across 3,132 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kriegstein received a total of $3,978 from 17 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kriegstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in MA
$3,978 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,341
Medicare services
Top 6% in MA for ophthalmology
3,132
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~544 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
4,800 | $29 | $50 |
| Ranibizumab-nuna biosimilar injection, 0.1 mg An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg. |
835 | $170 | $332 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
801 | $91 | $275 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
789 | $31 | $125 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
532 | $88 | $401 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $85 | $300 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
243 | $26 | $125 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
202 | $31 | $128 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
200 | $63 | $215 |
| Aflibercept eye injection (Eylea) | 198 | $689 | $1,194 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
193 | $46 | $165 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
182 | $408 | $1,935 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
173 | $54 | $150 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
130 | $28 | $180 |
| Injection, ranibizumab, 0.1 mg | 130 | $176 | $480 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
113 | $245 | $725 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
96 | $13 | $65 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $40 | $95 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
83 | $94 | $350 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
53 | $22 | $35 |
| Visual field test, limited A test that measures your side (peripheral) vision. This limited version assesses a restricted portion of your visual field. |
39 | $27 | $65 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
37 | $112 | $265 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $110 | $350 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
23 | $675 | $2,300 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
23 | $185 | $841 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
23 | $575 | $2,225 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
20 | $18 | $65 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
14 | $15 | $99 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
12 | $21 | $75 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
11 | $703 | $2,525 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
74.8% medium
23.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,978
Total received (2018-2024)
Avg $663/year across 6 years
Top 20% in MA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
47
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,380 (85.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$550 (13.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$167
2023
$126
2022
$2,597
2020
$73
2019
$119
2018
$895
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$69
Coherus Biosciences Inc.
$38
Sandoz Inc.
$29
Tarsus Pharmaceuticals, Inc.
$19
ABBVIE INC.
$13
Top 3 companies account for 80.9% of 2024 payments
All-time payments by company (2018-2024) ›
BioTissue Holdings, Inc.
$2,567
Regeneron Pharmaceuticals, Inc.
$550
Regeneron Healthcare Solutions, Inc.
$174
Alcon Vision LLC
$153
Shire North American Group Inc
$141
Spark Therapeutics, Inc.
$48
Apellis Pharmaceuticals, Inc.
$47
ABBVIE INC.
$43
Genentech USA, Inc.
$42
Coherus Biosciences Inc.
$38
Aerie Pharmaceuticals, Inc.
$38
Biogen, Inc.
$38
Sandoz Inc.
$29
Allergan Inc.
$23
Allergan, Inc.
$19
Tarsus Pharmaceuticals, Inc.
$19
Alimera Sciences, Inc.
$10
Top 3 companies account for 82.7% of all-time payments
Associated products mentioned in payments ›
ARGOS · COMBIGAN · Cimerli · Clareon · EYLEA · EYLEA AFLIBERCEPT INJECTION · LUMIGAN · LUXTURNA · OZURDEX · PROKERA · Rhopressa · Syfovre · VABYSMO · VUITY · Vabysmo · XDEMVY · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
15
Per 100K population
2.8
County median income
$109,698
Nearest hospital
BETH ISRAEL DEACONESS HOSPITAL PLYMOUTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kriegstein is a mixed practice specialist, with above-average Medicare volume (top 6% in MA), with low-engagement industry engagement in the top 20% of MA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kriegstein experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Kriegstein performed 4,800 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kriegstein receive payments from pharmaceutical companies?
Yes. Dr. Kriegstein received a total of $3,978 from 17 companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kriegstein's costs compare to other ophthalmologists in Plymouth?
Dr. Kriegstein's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kriegstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Plymouth
Browse ophthalmologists in Plymouth ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in MA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in MA
Which MA ophthalmologists receive the most from drug and device companies.
By company
BioTissue Holdings, Inc. Payments to Doctors
See all physicians who received payments from BioTissue Holdings, Inc.
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology